As of Apr 2, 2025, the USNA stock has a PE ratio of 12.34. The calculation is based on the latest EPS of $2.2 and the stock price of $27.15 per share. A decrease of 18% has been observed in the PE ratio compared to its average of 15.1 of the last four quarters.
The mean historical PE ratio of Usana Health Sciences over the last ten years is 17.68. The current 12.34 P/E ratio is 30% lower than the historical average. Looking back at the last ten years, USNA's PE ratio peaked in the Jun 2018 quarter at 34.42, with a price of $115.3 and an EPS of $3.35. The Mar 2020 quarter marked the lowest point at 12.76, with a price of $59.35 and an EPS of $4.65.
Maximum annual increase: 94.93% in 2013
Maximum annual decrease: -37.75% in 2011
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 16.22 | 0.19% | $35.69 | $2.2 |
2023 | 16.19 | 9.54% | $53.6 | $3.31 |
2022 | 14.78 | -15.59% | $53.2 | $3.6 |
2022 | 17.51 | 33.77% | $101.2 | $5.78 |
2021 | 13.09 | -27.36% | $77.1 | $5.89 |
2019 | 18.02 | -17.87% | $80 | $4.44 |
2018 | 21.94 | -23.85% | $114.96 | $5.24 |
2017 | 28.81 | 94.93% | $74.05 | $2.57 |
2016 | 14.78 | -13.92% | $61.2 | $4.14 |
2016 | 17.17 | -2.61% | $63.88 | $3.72 |
2015 | 17.63 | 31.08% | $51.14 | $2.9 |
2013 | 13.45 | 94.93% | $38.86 | $2.89 |
2012 | 6.9 | -25% | $15.8 | $2.29 |
2011 | 9.2 | -37.75% | $15.19 | $1.65 |
2011 | 14.78 | 1.93% | $21.73 | $1.47 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | 16.22 | 21.5% | $35.69 | $2.2 |
Sep 2024 | 13.35 | -15.29% | $37.92 | $2.84 |
Jun 2024 | 15.76 | 4.3% | $45.24 | $2.87 |
Mar 2024 | 15.11 | -6.67% | $48.5 | $3.21 |
Dec 2023 | 16.19 | -14.65% | $53.6 | $3.31 |
Sep 2023 | 18.97 | -1.3% | $58.61 | $3.09 |
Jul 2023 | 19.22 | 3.61% | $63.04 | $3.28 |
Apr 2023 | 18.55 | 25.51% | $62.9 | $3.39 |
Dec 2022 | 14.78 | 5.5% | $53.2 | $3.6 |
Oct 2022 | 14.01 | -14.26% | $56.05 | $4 |
Jul 2022 | 16.34 | 12.85% | $75 | $4.59 |
Apr 2022 | 14.48 | -17.3% | $79.33 | $5.48 |
Jan 2022 | 17.51 | 23.66% | $101.2 | $5.78 |
Oct 2021 | 14.16 | -7.21% | $93.58 | $6.61 |
Jul 2021 | 15.26 | -5.69% | $102.12 | $6.69 |
The current PE ratio of USNA is lower than its 3, 5 and 10-year averages.
USNA's PE ratio stands lower than its peer stocks IPAR and NATR, but it is higher than HLF's and MTEX's. Usana Health Sciences is currently trading at a lower PE ratio (12.34) than its peers average of 15.6.
Stock name | PE ratio | Market cap |
---|---|---|
HLF Herbalife Nutrition Ltd | 3.49 | $893.57M |
MTEX Mannatech Inc | 6.38 | $16.01M |
USNA Usana Health Sciences Inc | 12.34 | $513.26M |
IPAR Inter Parfums Inc | 22.32 | $3.68B |
NATR Natures Sunshine Products Inc | 30.22 | $229.01M |
NUS Nu Skin Enterprises Inc | N/A | $354.52M |
PRPH ProPhase Labs Inc | N/A | $16.33M |
The price to earnings ratio for USNA stock as of Apr 2, 2025, stands at 12.34.
The average PE ratio for USNA stock over the past 3 years is 16.23.
The average PE ratio for USNA stock over the past 5 years is 15.61.
Over the last ten years, the Jun 2018 quarter recorded the highest quarterly PE ratio at 34.42.
USNA's current price to earnings ratio is 30% below its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Apr 2, 2025), Usana Health Sciences's share price is $27.15. The company's earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.2. Therefore, Usana Health Sciences's PE ratio for today is 12.34. PE RATIO(12.34) = STOCK PRICE($27.15) / TTM EPS($2.2)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.